Collecting, analyzing and interpreting patient-reported outcome (PRO) data for oncology trials can present unique challenges. Join us as our panel of experts discuss these challenges and talk about how to overcome them.
- The specific challenges associated with data analysis from cancer studies.
- Why safety and patient-reported outcome endpoints may appear contradictory in cancer trials.
- Why traditional statistical methods for clinical trials can lead to biased results when applied to oncology studies.
- Possible analytic methods to help account for potential biases and help you better understand your patients.